The relationship between excessive daytime sleepiness and metabolic syndrome in severe obstructive sleep apnea syndrome

Clinical Respiratory Journal

Volumn 10, Issue 6, 2016, Pages 714-721

  Huang, Jie Feng ^a   Chen, Li Da ^a   Lin, Qi Chang ^a   Chen, Gong Ping ^a   Yu, Yao Hua ^a   Huang, Jian Chai ^a   Zhao, Jian Ming ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

excessive daytime sleepiness; hypoxemia; metabolic syndrome; obstructive sleep apnea

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; EXCESSIVE DAYTIME SLEEPINESS; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SCORE; METABOLIC SYNDROME X; NECK CIRCUMFERENCE; OBESITY; POLYSOMNOGRAPHY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SOMNOLENCE;

ADULT; CROSS-SECTIONAL STUDIES; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME; MIDDLE AGED; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84924022935     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12276     Document Type: Article

References (29)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17): 1230–1235.
2. McNicholas WT, Bonsigore MR, Management Committee of ECAB. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J. 2007;29(1): 156–178.
3. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25(9): 735–741.
4. Redline S, Storfer-Isser A, Rosen CL, Johnson NL, Kirchner HL, Emancipator J, Kibler AM. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med. 2007;176(4): 401–408.
5. Vgontzas AN, Bixler EO, Chrousos GP. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev. 2005;9(3): 211–224.
6. Mediano O, Barcelo A, de la Pena M, Gozal D, Agusti A, Barbe F. Daytime sleepiness and polysomnographic variables in sleep apnoea patients. Eur Respir J. 2007;30(1): 110–113.
7. Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 2005;90(8): 4510–4515.
8. Barcelo A, Barbe F, de la Pena M, Martinez P, Soriano JB, Pierola J, Agusti AG. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax. 2008;63(11): 946–950.
9. Lindberg E, Berne C, Franklin KA, Svensson M, Janson C. Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women–a population-based study. Respir Med. 2007;101(6): 1283–1290.
10. Kapur VK, Resnick HE, Gottlieb DJ. Sleep disordered breathing and hypertension: does self-reported sleepiness modify the association? Sleep. 2008;31(8): 1127–1132.
11. Feng J, He QY, Zhang XL, Chen BY. Epworth sleepiness scale may be an indicator for blood pressure profile and prevalence of coronary artery disease and cerebrovascular disease in patients with obstructive sleep apnea. Sleep Breath. 2012;16(1): 31–40.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7): 412–419.
13. Schulz H. Phasic or transient? Comment on the terminology of the AASM manual for the scoring of sleep and associated events. J Clin Sleep Med. 2007;3(7): 752.
14. Chen NH, Johns MW, Li HY, Chu CC, Liang SC, Shu YH, Chuang ML, Wang PC. Validation of a Chinese version of the Epworth sleepiness scale. Qual Life Res. 2002;11(8): 817–821.
15. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17): 2735–2752.
16. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care. 2004;27(5): 1182–1186.
17. Chen R, Xiong KP, Lian YX, Huang JY, Zhao MY, Li JX, Liu CF. Daytime sleepiness and its determining factors in Chinese obstructive sleep apnea patients. Sleep Breath. 2011;15(1): 129–135.
18. Goldstein IB, Ancoli-Israel S, Shapiro D. Relationship between daytime sleepiness and blood pressure in healthy older adults. Am J Hypertens. 2004;17(9): 787–792.
19. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. A randomized, controlled trial. Ann Intern Med. 2001;134(11): 1015–1023.
20. Robinson GV, Stradling JR, Davies RJ. Sleep. 6: obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax. 2004;59(12): 1089–1094.
21. Bonsignore MR, Esquinas C, Barcelo A, Sanchez-de-la-Torre M, Paterno A, Duran-Cantolla J, Marin JM, Barbe F. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J. 2012;39(5): 1136–1143.
22. Ronksley PE, Hemmelgarn BR, Heitman SJ, Hanly PJ, Faris PD, Quan H, Tsai WH. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax. 2009;64(10): 834–839.
23. Drager LF, Lopes HF, Maki-Nunes C, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS ONE. 2010;5(8): e12065.
24. Dixon JB, Dixon ME, Anderson ML, Schachter L, O'Brien PE. Daytime sleepiness in the obese: not as simple as obstructive sleep apnea. Obesity. 2007;15(10): 2504–2511.
25. Nena E, Steiropoulos P, Papanas N, Tsara V, Fitili C, Froudarakis ME, Maltezos E, Bouros D. Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. Sleep Breath. 2012;16(1): 181–186.
26. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007;175(8): 851–857.
27. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4): 1897–1904.
28. Row BW, Liu R, Xu W, Kheirandish L, Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med. 2003;167(11): 1548–1553.
29. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res. 2000;9(1): 5–11.